Research study Program year 2022 Source: CMS Open Payments

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Sage-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia

ClinicalTrials.gov NCT03771664

Research payments

$1,022,924

171 payments

Through program year 2022, $1,022,924 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Sage-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia, across 171 payments, paid by Sage Therapeutics, Inc..

Paid by: Sage Therapeutics, Inc.
ClinicalTrials.gov: NCT03771664

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$2,972	1
2020	Research	$1,019,952	170

Breakdown

Who paid Research payments · program years 2020–2022

Sage Therapeutics, Inc. $1,022,924 171 payments

Who received the money Research payments · program years 2020–2022

Chicago Research Center INC Organisation paid for research $220,135 7 payments
Artemis Institute For Clinical Research Organisation paid for research $100,256 8 payments
Research Centers Of America LLC Organisation paid for research $92,980 7 payments
Erg Holding Company LLC Organisation paid for research $71,286 16 payments
Oregon Center For Clinical Investigations INC Organisation paid for research $51,830 9 payments
Gulfcoast Psychiatric Associates LLC Organisation paid for research $51,654 33 payments
Spri Clinical Trials LLC Organisation paid for research $48,764 4 payments
Iresearch Atlanta LLC Organisation paid for research $47,122 3 payments
Behavioral Clinical Research INC Organisation paid for research $45,180 10 payments
Excell Research Organisation paid for research $39,011 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.